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In blood cells RUNX1 directly stimulates G1 to S cell-cycle pro-
gression and regulates speciﬁc genes and cytokine receptors. In
addition, genetic variation in the RUNX1 gene has been implicated
in susceptibility to rheumatoid arthritis in Japanese populations.
We hypothesized that variation in the RUNX1 gene could be
involved in genetic susceptibility to osteoarthritis.
Methods: 1983 knee OA cases (1232 total knee replacement pa-
tients and 751 with radiographic disease only), 1283 hip OA cases
(1119 total hip replacement patients and 149 with radiographic
disease only) and 2317 controls from the UK were genotyped
for three tagging single nucleotide polymorphisms (SNPs) in the
RUNX1 gene and genetic association was tested.
Results: Differences in allele frequencies did not achieve sta-
tistical signiﬁcance between hip OA and controls (p<0.065) nor
between knee OA and controls (p< 0.370). Nevertheless, we found
that the rare homozygotes at both rs2834656 and rs2834662 were
signiﬁcantly associated with lower risk of hip OA OR=0.63 (95% CI
0.46-0.88) p<0.006 and OR=0.70 (95% CI 0.51-0.94) p<0.019 re-
spectively. No such association was seen with knee OA (OR=0.88,
95% CI 0.67- 1.15 and p=0.358)
Conclusions:Our data indicate that polymorphisms in the RUNX1
gene may be involved in genetic susceptibility of hip OA but not
knee OA.This work was supported by the Arthritis and Research
Campaign and by the European Union FP7 large collaborative
project grant 200800 TREAT-OA
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Purpose: Gene activity can be regulated or silenced by epi-
genetic control mechanisms, for example methylation. An EN-
CODE dataset of genome wide transcriptional repressor CCCTC-
binding factor (CTCF) binding shows a CTCF binding peak in the
proximity of rs225014, an OA susceptibility SNP within the DIO2
gene. In this study we set off to explore differences in methylation
status of DIO2 between blood and cartilage DNA as well as in
healthy and OA cartilage.
Methods: We collected cartilage material from subjects under-
going total joint arthroplasty and whole blood from OA patients.
Cartilage was snap frozen in liquid nitrogen and stored at -80°C.
Cartilage was ground up in a Retsch MM200 sample disintegrator
and RNA and DNA were extracted using Qiagen columns. Blood
DNA was collected by use of a Qiagen column. DNA was bisulﬁte
treated using the Zymo Research EZ DNA methylation bisulﬁte
kit and 13 DIO2 CpG sites were PCR ampliﬁed and quantitatively
assessed for DNA methylation using a mass spectrometry based
method (Epityper, Sequenom).
Results: The DNA methylation levels in cartilage (N=3) and blood
(N=7) could be analyzed for 12 out of 13 DIO2 CpG dinucleotides.
Overall, our preliminary data show that blood DNA performed
better upon bisulﬁte treatment as compared to cartilage DNA,
giving more robust data for blood. However, overall the methylation
status of the DIO2 in cartilage appeared higher as compared to
blood. For blood the average DIO2 methylation was 0.67, with
methylation status per CpG dinucleotide ranging from an average
of 0.1 to 0.96 (mean standard deviation 0.23 ranging from 0.04 to
0.17).
Conclusions: These preliminary data indicate that CpG methy-
lation within the DIO2 gene varies between individuals and that
we can consistently measure this variation. The overall hyper-
methylation of DIO2 in healthy cartilage as compared to blood
might be indicative of epigenetic control of the DIO2 within dif-
ferent tissues. This should be substantiated through the ongoing
collection of DNA from both healthy and OA affected cartilage,
which may also provide insights in possible differential methylation
of DIO2 in OA. Unraveling epigenetic regulation at developmental
genes within cartilage may elucidate additional mechanisms of the
complex etiology of OA.
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Purpose: Although the number of candidate genes has increased
and several polymorphisms have been studied in human popu-
lations, knowledge about genetic factors underlying the suscep-
tibility to obesity remains incomplete. This study assessed the
contribution of leptin gene polymorphism to BMI in Chinese Han
population.
Methods: 3 tag SNPs of LEP were selected by haploviewer
software from Hapmap database. They cover all the SNPs of
LEP whose heterozygosis rate are over 10%. We genotyped the
selected SNPs in 615 individuals ≥40 years old live in and around
Nanjing, China, compared allelic and genotypic frequencies and
haplotype distribution between normal range (BMI = 18.50-24.99)
and overweight (BMI ≥ 25.00) groups.
Results: Associations were observed in haplotype CAT (P=0.009)
and AGC (P=0.005) between the two groups, with the sequence
of loci chosen for hap-analysis is rs11761556, rs12706832,
rs2071045. No association between the genotypes and allele
frequences was observed between the two groups.
Conclusions: These ﬁndings suggest there is an association be-
tween LEP and BMI and it’s a ﬁrst report examined the relationship
between LEP polymorphisms and BMI in Han Chinese.
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Purpose: Lumbar disc herniation (LDH) is a common disease,
a predominant cause of low back pain and unilateral leg pain.
Although many risk factors have been reported for LDH, its etiol-
ogy and pathogenesis are for the most part unknown. The strong
familial predisposition for LDH and lumbar disc degeneration has
been established through a number of family and twin studies.
Recently, several susceptibility genes have been reported to asso-
ciate with LDH and related conditions. Most encode extracellular
matrix (ECM) proteins in the intervertebral disc, suggesting the
importance of ECM metabolism in LDH. The aim of the study is
to examine susceptibility genes for LDH through a candidate gene
approach for the cartilage genes.
Methods: Subjects.
Case-control association analyses were performed for LDH can-
didate genes by a two-step screening. We recruited a total of
nearly 1,000 cases and 1,000 controls for the ﬁrst screen and
the replication study. Affected individuals with LDH were recruited
from 19 collaborating hospitals. The diagnosis of LDH required the
following three criteria: 1) diagnosis of LDH by MRI; 2) treatment
and monitoring for >1 year by orthopedic surgeons; and 3) a
history of unilateral pain radiating from the back along the femoral
or sciatic nerve to the corresponding dermatome of the nerve
